115 related articles for article (PubMed ID: 37071335)
1. A Comparison of COVID-19 Vaccine and PrEP Hesitancy Among Individuals Living in Mississippi: A Qualitative Study.
Arnold T; Barnett AP; Giorlando KK; Leigland A; Sims-Gomillia C; Whiteley L; Brown LK
AIDS Behav; 2023 Oct; 27(10):3515-3520. PubMed ID: 37071335
[TBL] [Abstract][Full Text] [Related]
2. A qualitative study evaluating COVID-19 vaccine hesitancy among individuals living in Mississippi.
Leigland A; Arnold T; Giorlando KK; Barnett AP; Sims-Gomillia CE; Bertone Z; Edet PP; Whiteley L; Brown LK
SSM Qual Res Health; 2024 Jun; 5():. PubMed ID: 38605935
[TBL] [Abstract][Full Text] [Related]
3. The effect of framing and communicating COVID-19 vaccine side-effect risks on vaccine intentions for adults in the UK and the USA: A structured summary of a study protocol for a randomized controlled trial.
Sudharsanan N; Favaretti C; Hachaturyan V; Bärnighausen T; Vandormael A
Trials; 2021 Sep; 22(1):592. PubMed ID: 34488843
[TBL] [Abstract][Full Text] [Related]
4. COVID-19 vaccine hesitancy in adults with multiple sclerosis in the United States: A follow up survey during the initial vaccine rollout in 2021.
Ehde DM; Roberts MK; Humbert AT; Herring TE; Alschuler KN
Mult Scler Relat Disord; 2021 Sep; 54():103163. PubMed ID: 34325399
[TBL] [Abstract][Full Text] [Related]
5. Considerations for PrEP Implementation at Federally Qualified Health Centers in Mississippi: Perspectives From Staff and Patients.
Barnett AP; Arnold T; Elwy AR; Brock JB; Giorlando KK; Sims-Gomillia C; Leigland A; Whiteley L; Brown LK
AIDS Educ Prev; 2023 Aug; 35(4):309-319. PubMed ID: 37535326
[TBL] [Abstract][Full Text] [Related]
6. Exploring COVID-19 Vaccine Hesitancy Amongst Black Americans: Contributing Factors and Motivators.
Sekimitsu S; Simon J; Lindsley MM; Jones M; Jalloh U; Mabogunje T; Kerr J; Willingham M; Ndousse-Fetter SB; White-Hammond G; Altman W
Am J Health Promot; 2022 Nov; 36(8):1304-1315. PubMed ID: 35506153
[TBL] [Abstract][Full Text] [Related]
7. Vaccine Hesitancy in Mississippi: Does Political Ideology Muddy the Waters?
Evans MW; Wajpe AS; Wari E; Aras S; Lemacks J
J Prim Care Community Health; 2023; 14():21501319231158518. PubMed ID: 36852739
[TBL] [Abstract][Full Text] [Related]
8. Identifying H1N1 and COVID-19 vaccine hesitancy or refusal among health care providers: a scoping review.
Gallant AJ; Harding A; Johnson C; Steenbeek A; Curran JA
JBI Evid Synth; 2023 May; 21(5):913-951. PubMed ID: 36917102
[TBL] [Abstract][Full Text] [Related]
9. Intervention Messaging About Pre-Exposure Prophylaxis Use Among Young, Black Sexual Minority Men.
Rogers BG; Whiteley L; Haubrick KK; Mena LA; Brown LK
AIDS Patient Care STDS; 2019 Nov; 33(11):473-481. PubMed ID: 31682168
[TBL] [Abstract][Full Text] [Related]
10. Exploring vaccine hesitancy in care home employees in North West England: a qualitative study.
Dennis A; Robin C; Jones LF; Carter H
BMJ Open; 2022 May; 12(5):e055239. PubMed ID: 35501075
[TBL] [Abstract][Full Text] [Related]
11. Hesitancy towards the COVID-19 vaccine among health care practitioners in the Kingdom of Saudi Arabia: a cross-sectional study.
Almojaibel AA; Ansari K; Alzahrani YA; Alessy SA; Farooqi FA; Alqurashi YD
F1000Res; 2022; 11():24. PubMed ID: 37360937
[TBL] [Abstract][Full Text] [Related]
12. COVID-19 vaccine hesitancy among people living with HIV in a low-resource setting: A multi-center study of prevalence, correlates and reasons.
Kabir Sulaiman S; Sale Musa M; Isma'il Tsiga-Ahmed F; Muhammad Dayyab F; Kabir Sulaiman A; Dabo B; Idris Ahmad S; Abubakar Haruna S; Abdurrahman Zubair A; Hussein A; Usman S; Usman Wada J; Yekeen Ayodele A; Wulgo Ali M; Tijjani Makama B; Tijjani Bako A;
Vaccine; 2023 Apr; 41(15):2476-2484. PubMed ID: 36932032
[TBL] [Abstract][Full Text] [Related]
13. Provider perspectives on service delivery modifications to maintain access to HIV pre-exposure prophylaxis during the COVID-19 pandemic: qualitative results from a PrEP implementation project in Kenya.
Velloza J; Roche SD; Owidi EJ; Irungu EM; Dollah A; Kwach B; Thuo NB; Morton JF; Mugo N; Bukusi EA; O'Malley G; Ngure K; Baeten JM; Mugwanya KK;
J Int AIDS Soc; 2023 Feb; 26(2):e26055. PubMed ID: 36739603
[TBL] [Abstract][Full Text] [Related]
14. Engagement With HIV and COVID-19 Prevention: Nationwide Cross-sectional Analysis of Users on a Geosocial Networking App.
Gaither TW; Sigalos JT; Landovitz RJ; Mills JN; Litwin MS; Eleswarapu SV
J Med Internet Res; 2022 Sep; 24(9):e38244. PubMed ID: 36026586
[TBL] [Abstract][Full Text] [Related]
15. "I think everybody should take it if they're doing drugs, doing heroin, or having sex for money": a qualitative study exploring perceptions of pre-exposure prophylaxis among female participants in an opioid intervention court program.
Przybyla SM; Cerulli C; Bleasdale J; Wilson K; Hordes M; El-Bassel N; Morse DS
Subst Abuse Treat Prev Policy; 2020 Nov; 15(1):89. PubMed ID: 33228721
[TBL] [Abstract][Full Text] [Related]
16. Strategies to improve PrEP uptake among West African men who have sex with men: a multi-country qualitative study.
Reyniers T; Babo SAY; Ouedraogo M; Kanta I; Ekon Agbégnigan L; Rojas D; Eubanks A; Anoma C; Dah TTE; Mensah E; Dembélé Keita B; Spire B; Vuylsteke B; Laurent C
Front Public Health; 2023; 11():1165327. PubMed ID: 37181706
[TBL] [Abstract][Full Text] [Related]
17. COVID-19 Vaccine Hesitancy Among PLWH in South India: Implications for Vaccination Campaigns.
Ekstrand ML; Heylen E; Gandhi M; Steward WT; Pereira M; Srinivasan K
J Acquir Immune Defic Syndr; 2021 Dec; 88(5):421-425. PubMed ID: 34757971
[TBL] [Abstract][Full Text] [Related]
18. Impact of Coronavirus Disease 2019 (COVID-19) on Human Immunodeficiency Virus (HIV) Pre-exposure Prophylaxis Prescriptions in the United States-A Time-Series Analysis.
Huang YLA; Zhu W; Wiener J; Kourtis AP; Hall HI; Hoover KW
Clin Infect Dis; 2022 Aug; 75(1):e1020-e1027. PubMed ID: 35040928
[TBL] [Abstract][Full Text] [Related]
19. Provider Perspectives on HIV Pre-Exposure Prophylaxis Service Disruptions and Adaptations During the COVID-19 Pandemic in Baltimore, Maryland: A Qualitative Study.
Rosen JG; Zhang L; Pelaez D; Coleman JS; To C; Cooper L; Olatunde PF; Toomre T; Glick JL; Park JN
AIDS Patient Care STDS; 2022 Aug; 36(8):313-320. PubMed ID: 35951445
[TBL] [Abstract][Full Text] [Related]
20. Exploring perceived risk for COVID-19 and its role in protective behavior and COVID-19 vaccine hesitancy: a qualitative study after the first wave.
Patterson NJ; Paz-Soldan VA; Oberhelman R; Moses L; Madkour A; Miles TT
BMC Public Health; 2022 Mar; 22(1):503. PubMed ID: 35292002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
